Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) are novel cancer therapeutics that address the immune system to attack malignancies. While this therapy has significantly improved the outcome of a variety of tumor patients, it has been associated with a new class of side effects, so-called immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dong, Bauersachs, Johann, Berliner, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045178/
https://www.ncbi.nlm.nih.gov/pubmed/36979163
http://dx.doi.org/10.3390/biology12030472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045178/
https://www.ncbi.nlm.nih.gov/pubmed/36979163
http://dx.doi.org/10.3390/biology12030472

Ejemplares similares